VENTIPULMIN DIN 00705845
Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: CLENBUTEROL HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | CLENBUTEROL HYDROCHLORIDE 0.025 MG |
|---|---|
| Dosage form | Syrup |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1988 |
| Current status date | 31-May-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLENBUTEROL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02380803 | RESPIPULMIN | MODERN VETERINARY THERAPEUTICS LLC | Syrup | CLENBUTEROL HYDROCHLORIDE 0.025 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25962 | 2021-05-31 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 22739 | 2019-10-02 | Supplement to a New Drug Submission (SNDS) | ADDITION OF DRUG SUBSTANCE MANUFACTURING SITE |
International API supply for CLENBUTEROL HYDROCHLORIDE
4 valid EDQM Certificates of Suitability from 4 holders. 1 active FDA Drug Master Files.
Request a quote for VENTIPULMIN